Day One Tuesday 18 November 2008 |
08:30 |
|
Registration |
09:00 |
Sean Davis
General Manager
FERRING IRELAND |
Opening remarks from the Chair |
Forecasting within the context of pharma |
09:10 |
Jennifer L. Castle
Postdoctoral Research Fellow
Department of Economics
Nuffield College
UNIVERSITY OF OXFORD |
Economic forecasting in uncertain environments
- Examining the main causes of forecast failure, defined as a large and sustained forecast error, in economic forecasting
- Identifying sudden, unanticipated large changes in mean as the main cause of forecast failure and considering its implications for forecast theory
- Developing robust methods to forecast when large shifts occur
|
Focusing on pricing developments and prediction |
09:50 |
Gabor Berta
Director
Pricing and Market Access
ASTRAZENECA |
Overcoming the challenge of getting the price right
- Examining major challenges in strategic product pricing
- Learning how to measure changes in price for accurate forecasts
- What are the proven practices of making the most accurate predictions?
|
10:30 |
|
Morning refreshments |
11:00 |
Dr Rainer Walenta
Director
Global Pricing and Reimbursement
SOLVAY PHARMACEUTICALS |
Analysing the impact of different pricing and reimbursement systems on the pharma industry
- Discussing the consequences of international reference pricing on local reimbursement
- Understanding the launch strategy, launch sequence and parallel trade
- Will a unified European pricing structure be the final outcome?
|
Achieving forecasting accuracy for new products |
| 11:40 |
Rafaat Rahmani
President
LIFESCIENCE DYNAMICS LTD |
How to choose market share techniques for a new product forecast
- Quick’n’dirty: implementing order of entry models to forecast early phase products
- Get expert opinions on analogue-based market share and Monte Carlo simulation and find out how these can benefit your forecasts
- Discover the benefits of fixed product and variable product profiles via market research departments
|
| 12:20 |
Gary Johnson
Managing Director
INPHARMATION |
Forecasting the uptake of new brands and new classes
- Best practice: how the best pharma companies do it
- Worst practice: frequently committed errors and how to avoid them
- The best and simplest approaches for developing the best forecasts
- Examples of famous pharma cases
|
| 13:00 |
|
Lunch |
| 14:20 |
Mercedes Diz
Head
In-Licensing
ALMIRALL |
Forecasting for in-licensed products
- Inherent challenges of business development projects
- Screening of opportunities, pre-confidentiality, due diligence and full analysis
- Role of forecasting in the negotiation process
|
Achieving forecasting excellence |
| 15:00 |
Robert Carbone
CEO
FUTURION
|
The principles of Total Market Forecasting
- What is Total Market Forecasting?
- Why Total Market Forecasting?
- What are the underlying principles?
- How can these principles be applied for different local market dynamics and data availability?
- Presenting a European case study in an excel free environment
|
| 15:40 |
|
Afternoon refreshments |
| 16:10 |
Marcel Fischer
Head
Supply Chain Management
SIEGFRIED ACTIVES |
Sales funnel: a concept to optimise forecasting for projects and products at Siegfried Actives
- Establishing a life-cycle management strategy
- Steering the supply chain with proper sales planning
- Supporting the processes with integrated tools
- Aligning the forecast with reality
- Lessons learned
|
| 16:50 |
Lars Nordmann
Head of Forecasting
SCHERING-PLOUGH |
Simultaneous versus sequential event valuation
- Understand that traditional forecasting software, commercial or customised, typically evaluates market events in a sequential fashion
- Learn why the order-induced valuation bias can easily yield misleading, inconsistent or even directionally wrong conclusions
- Discover a simple analytic fix that eliminates the order bias and provides a sound mathematical basis for event valuations
|
| 17:30 |
|
Closing remarks from the Chair and end of Day One |
|
|
|
Day Two Wednesday 19 November 2008 |
| 08:00 |
|
Registration |
| |
|
Opening remarks from the Chair |
| |
ROUNDTABLE MORNING |
Delegates will be able to attend three one-hour roundtable discussion groups from a selection of key topics. Each session will be chaired by an industry expert who will facilitate an exchange of opinions, essential experiences and learning related to a current aspect of forecasting techniques and strategies. |
| |
| |
|
|
|
|
|
| 1. |
Prediction and analysis of long-term ROIs
Lars Nordmann
Head of Forecasting
SCHERING-PLOUGH |
2. |
Examining proven practices in price forecasting
Dr Rainer Walenta
Director
Global Pricing and Reimbursement
SOLVAY PHARMACEUTICALS |
3. |
Discussing the challenges of operational forecasting
Robert Carbone
CEO
FUTURION |
| |
|
|
|
|
|
| 4. |
Achieving accurate sales forecasts
Manuel Reiberg
Senior Manager Market Research Europe
DAIICHI SANKYO |
5. |
Best practice approaches to market research
Werner Gorath
Group Manager
Market Research
NYCOMED |
|
|
| |
|
|
|
|
|
|
| 12:30 |
|
Lunch |
Aligning market research and forecasting to improve business result |
| 13:50 |
Werner Gorath
Group Manager
Market Research
NYCOMED |
Integrating market research into corporate decision-making
- Identifying the best methodologies in market research
- Strengthening strategic planning by aligning market research and forecasting data
- Effective analysis and management reporting
- Creating an integrated business intelligence approach
|
| 14:30 |
Manuel Reiberg
Senior Manager
Market Research
Europe
DAIICHI SANKYO |
Medium-term sales forecasting in a stable market environment
- Understand how Daiichi-Sankyo has created a major product line in the European hypertension market and delivered accurate forecasts
- Discover how to establish a new forecasting process in order to increase the forecast accuracy across the European business
- Understand how to successfully align headquarters as well as affiliate level forecasting
|
| 15:10 |
Roger Holdsworth
Associate Director
Portfolio Analysis
UCB |
The importance of forecasting data for portfolio analysis and management across the product lifecycle
- Discussing portfolio analysis and management and its importance in decision making within the pharma industry
- Examining the value and validity of the analytical data - highly dependent upon the quality of the input
- Understanding how, for later phase projects in particular, precise and accurate revenue forecasts are central to value analysis
- Looking at the importance of consistent approaches to forecasting when comparing projects within the portfolio
- Focusing on portfolio analysis and management across the development cycle with particular emphasis on the forecasting input
|
| 15:50 |
|
Closing remarks from the Chair and farewell tea and coffee |
| |
|
|
|
 |
|